MedTrace Logo

Gut Microbiome and Colorectal Cancer

NCT06748339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2024-12-27

No results posted yet for this study

Summary

Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries. It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle. In Egypt, CRC represents the seventh most common cancer. It is the third most reported cancer in males and the fifth most common cancer in females. microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target

Conditions

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Heliopolis University

    lead OTHER

Principal Investigators

  • sara M eladwy · Heliopolis University

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-09-17
Completion
2024-12-17

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06748339 on ClinicalTrials.gov